Research.Patient.info
Gastro-enteropancreatic Neuroendocrine Tumor research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
This study looked at a new treatment called Lutathera for advanced bowel and stomach neuroendocrine tumours (NETs). It compared Lutathera plus standard long-acting octreotide against a higher dose of octreotide alone, to see if it helped patients live longer without their cancer growing.
United States · Canada · France - active not recruitingPHASE3
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
This study is testing a new medicine, CAM2029, for a type of cancer called GEP-NET. It compares CAM2029 to existing treatments, octreotide LAR and lanreotide ATG, to see if it's more effective and safe for advanced GEP-NET.
United States · Australia · Belgium